Australia's most trusted
source of pharma news
Wednesday, 16 October 2024
Posted 15 October 2024 AM
Two more Australians have packed their bags and passports for overseas gigs with executives at Johnson & Johnson and Novo Nordisk nabbing major global promotions.
Novo's Ruchi Kanojia has landed in Copenhagen to kick off in her new role as Global Value Strategy and Payer Engagement Lead - Rare Diseases.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.